Neurocrine Biosciences (NBIX) Tax Rate (2019 - 2026)

Neurocrine Biosciences (NBIX) has reported Tax Rate for 8 consecutive years, with 10.97% the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Tax Rate fell 2163.0% year-over-year to 10.97%; the trailing twelve-month figure through Jun 2026 stood at 24.96% (down 896.0% YoY), and the FY2025 full-year result was 32.15%, up 238.0% from the prior year.
• Tax Rate retreated to 10.97% in Q2 2026 per NBIX's latest filing, from 19.81% in the prior quarter.
• Across five years, Tax Rate topped out at 46.26% in Q1 2025 and bottomed at 25.8% in Q1 2024.
• Historically, Tax Rate has averaged 26.02% across 5 years, with a median of 28.16% in 2023.
• The sharpest annual moves came in 2024 and 2025: Tax Rate plunged 5164 bps in 2024, then jumped 7206 bps in 2025.
• Over 5 years, Tax Rate stood at 24.51% in 2022, then increased by 4 bps to 25.48% in 2023, then jumped by 44 bps to 36.59% in 2024, then fell by 2 bps to 35.8% in 2025, then slumped by 69 bps to 10.97% in 2026.
• According to Business Quant data, Tax Rate over the past three periods registered 10.97%, 19.81%, and 35.8% for Q2 2026, Q1 2026, and Q4 2025 respectively.